Loading...
Autophagy inhibition contributes to Endostar sensitization in esophageal squamous cell carcinoma
Endostar is a novel artificially-synthesized anti-angiogenesis drug, and has been approved for clinical use. Previous studies have indicated that patients with esophageal cancer could benefit from Endostar combined with chemotherapy or chemoradiotherapy. However, the most advantageous use of this dr...
Na minha lista:
| Udgivet i: | Oncol Lett |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5686445/ https://ncbi.nlm.nih.gov/pubmed/29163691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7017 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|